Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

DLHC vs CRAI

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
DLHC
DLH Holdings Corp.

Specialty Business Services

NASDAQ • US
Market Cap$83M
5Y Perf.-22.6%
CRAI
CRA International, Inc.

Consulting Services

IndustrialsNASDAQ • US
Market Cap$899M
5Y Perf.+244.4%

DLHC vs CRAI — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
DLHC logoDLHC
CRAI logoCRAI
IndustrySpecialty Business ServicesConsulting Services
Market Cap$83M$899M
Revenue (TTM)$293M$771M
Net Income (TTM)$-4M$48M
Gross Margin14.4%20.3%
Operating Margin2.5%9.8%
Forward P/E60.8x16.9x
Total Debt$145M$127M
Cash & Equiv.$125K$18M

DLHC vs CRAILong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

DLHC
CRAI
StockMay 20May 26Return
DLH Holdings Corp. (DLHC)10077.4-22.6%
CRA International, … (CRAI)100344.4+244.4%

Price return only. Dividends and distributions are not included.

Quick Verdict: DLHC vs CRAI

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: CRAI leads in 6 of 7 categories, making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. DLH Holdings Corp. is the stronger pick specifically for recent price momentum and sentiment. As sector peers, any of these can serve as alternatives in the same allocation.
DLHC
DLH Holdings Corp.
The Momentum Pick

DLHC is the clearest fit if your priority is momentum.

  • +41.5% vs CRAI's -20.7%
Best for: momentum
CRAI
CRA International, Inc.
The Income Pick

CRAI carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • Dividend streak 9 yrs, beta 0.73, yield 1.5%
  • Rev growth 9.3%, EPS growth 20.8%, 3Y rev CAGR 8.3%
  • 5.5% 10Y total return vs DLHC's 24.0%
Best for: income & stability and growth exposure
See the full category breakdown
CategoryWinnerWhy
GrowthCRAI logoCRAI9.3% revenue growth vs DLHC's -13.0%
ValueCRAI logoCRAILower P/E (16.9x vs 60.8x)
Quality / MarginsCRAI logoCRAI6.2% margin vs DLHC's -1.5%
Stability / SafetyCRAI logoCRAIBeta 0.73 vs DLHC's 0.82, lower leverage
DividendsCRAI logoCRAI1.5% yield; 9-year raise streak; the other pay no meaningful dividend
Momentum (1Y)DLHC logoDLHC+41.5% vs CRAI's -20.7%
Efficiency (ROA)CRAI logoCRAI7.6% ROA vs DLHC's -1.6%, ROIC 20.4% vs 4.7%

DLHC vs CRAI — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

DLHCDLH Holdings Corp.
FY 2025
Time-and-Materials Contract
65.4%$177M
Fixed-Price Contract
34.6%$94M
CRAICRA International, Inc.
FY 2025
Time-and-Materials Contract
82.6%$621M
Fixed-Price Contract
17.4%$131M

DLHC vs CRAI — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLCRAILAGGINGDLHC

Income & Cash Flow (Last 12 Months)

CRAI leads this category, winning 5 of 6 comparable metrics.

CRAI is the larger business by revenue, generating $771M annually — 2.6x DLHC's $293M. CRAI is the more profitable business, keeping 6.2% of every revenue dollar as net income compared to DLHC's -1.5%. On growth, CRAI holds the edge at +10.5% YoY revenue growth, suggesting stronger near-term business momentum.

MetricDLHC logoDLHCDLH Holdings Corp.CRAI logoCRAICRA International…
RevenueTrailing 12 months$293M$771M
EBITDAEarnings before interest/tax$25M$98M
Net IncomeAfter-tax profit-$4M$48M
Free Cash FlowCash after capex$19M-$17M
Gross MarginGross profit ÷ Revenue+14.4%+20.3%
Operating MarginEBIT ÷ Revenue+2.5%+9.8%
Net MarginNet income ÷ Revenue-1.5%+6.2%
FCF MarginFCF ÷ Revenue+6.5%-2.2%
Rev. Growth (YoY)Latest quarter vs prior year-33.6%+10.5%
EPS Growth (YoY)Latest quarter vs prior year-4.0%-35.5%
CRAI leads this category, winning 5 of 6 comparable metrics.

Valuation Metrics

DLHC leads this category, winning 4 of 5 comparable metrics.

At 17.1x trailing earnings, CRAI trades at a 72% valuation discount to DLHC's 60.8x P/E. On an enterprise value basis, DLHC's 6.7x EV/EBITDA is more attractive than CRAI's 10.4x.

MetricDLHC logoDLHCDLH Holdings Corp.CRAI logoCRAICRA International…
Market CapShares × price$83M$899M
Enterprise ValueMkt cap + debt − cash$228M$1.0B
Trailing P/EPrice ÷ TTM EPS60.83x17.09x
Forward P/EPrice ÷ next-FY EPS est.16.88x
PEG RatioP/E ÷ EPS growth rate0.79x
EV / EBITDAEnterprise value multiple6.71x10.36x
Price / SalesMarket cap ÷ Revenue0.24x1.20x
Price / BookPrice ÷ Book value/share0.73x4.37x
Price / FCFMarket cap ÷ FCF3.61x48.45x
DLHC leads this category, winning 4 of 5 comparable metrics.

Profitability & Efficiency

CRAI leads this category, winning 8 of 9 comparable metrics.

CRAI delivers a 23.6% return on equity — every $100 of shareholder capital generates $24 in annual profit, vs $-4 for DLHC. CRAI carries lower financial leverage with a 0.60x debt-to-equity ratio, signaling a more conservative balance sheet compared to DLHC's 1.28x. On the Piotroski fundamental quality scale (0–9), DLHC scores 5/9 vs CRAI's 4/9, reflecting solid financial health.

MetricDLHC logoDLHCDLH Holdings Corp.CRAI logoCRAICRA International…
ROE (TTM)Return on equity-4.0%+23.6%
ROA (TTM)Return on assets-1.6%+7.6%
ROICReturn on invested capital+4.7%+20.4%
ROCEReturn on capital employed+6.6%+26.9%
Piotroski ScoreFundamental quality 0–954
Debt / EquityFinancial leverage1.28x0.60x
Net DebtTotal debt minus cash$145M$109M
Cash & Equiv.Liquid assets$125,000$18M
Total DebtShort + long-term debt$145M$127M
Interest CoverageEBIT ÷ Interest expense0.46x14.51x
CRAI leads this category, winning 8 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

CRAI leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in CRAI five years ago would be worth $17,152 today (with dividends reinvested), compared to $5,601 for DLHC. Over the past 12 months, DLHC leads with a +41.5% total return vs CRAI's -20.7%. The 3-year compound annual growth rate (CAGR) favors CRAI at 15.5% vs DLHC's -17.6% — a key indicator of consistent wealth creation.

MetricDLHC logoDLHCDLH Holdings Corp.CRAI logoCRAICRA International…
YTD ReturnYear-to-date+2.7%-30.3%
1-Year ReturnPast 12 months+41.5%-20.7%
3-Year ReturnCumulative with dividends-44.1%+54.1%
5-Year ReturnCumulative with dividends-44.0%+71.5%
10-Year ReturnCumulative with dividends+24.0%+550.5%
CAGR (3Y)Annualised 3-year return-17.6%+15.5%
CRAI leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

Evenly matched — DLHC and CRAI each lead in 1 of 2 comparable metrics.

CRAI is the less volatile stock with a 0.73 beta — it tends to amplify market swings less than DLHC's 0.82 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. DLHC currently trades 70.7% from its 52-week high vs CRAI's 61.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricDLHC logoDLHCDLH Holdings Corp.CRAI logoCRAICRA International…
Beta (5Y)Sensitivity to S&P 5000.82x0.73x
52-Week HighHighest price in past year$8.10$227.29
52-Week LowLowest price in past year$3.95$135.95
% of 52W HighCurrent price vs 52-week peak+70.7%+61.2%
RSI (14)Momentum oscillator 0–10045.441.1
Avg Volume (50D)Average daily shares traded8K187K
Evenly matched — DLHC and CRAI each lead in 1 of 2 comparable metrics.

Analyst Outlook

CRAI leads this category, winning 1 of 1 comparable metric.

CRAI is the only dividend payer here at 1.48% yield — a key consideration for income-focused portfolios.

MetricDLHC logoDLHCDLH Holdings Corp.CRAI logoCRAICRA International…
Analyst RatingConsensus buy/hold/sellBuy
Price TargetConsensus 12-month target$194.00
# AnalystsCovering analysts1
Dividend YieldAnnual dividend ÷ price+1.5%
Dividend StreakConsecutive years of raises19
Dividend / ShareAnnual DPS$2.06
Buyback YieldShare repurchases ÷ mkt cap0.0%+5.2%
CRAI leads this category, winning 1 of 1 comparable metric.
Key Takeaway

CRAI leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). DLHC leads in 1 (Valuation Metrics). 1 tied.

Best OverallCRA International, Inc. (CRAI)Leads 4 of 6 categories
Loading custom metrics...

DLHC vs CRAI: Frequently Asked Questions

9 questions · data-driven answers · updated daily

01

Is DLHC or CRAI a better buy right now?

For growth investors, CRA International, Inc.

(CRAI) is the stronger pick with 9. 3% revenue growth year-over-year, versus -13. 0% for DLH Holdings Corp. (DLHC). CRA International, Inc. (CRAI) offers the better valuation at 17. 1x trailing P/E (16. 9x forward), making it the more compelling value choice. Analysts rate CRA International, Inc. (CRAI) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — DLHC or CRAI?

On trailing P/E, CRA International, Inc.

(CRAI) is the cheapest at 17. 1x versus DLH Holdings Corp. at 60. 8x.

03

Which is the better long-term investment — DLHC or CRAI?

Over the past 5 years, CRA International, Inc.

(CRAI) delivered a total return of +71. 5%, compared to -44. 0% for DLH Holdings Corp. (DLHC). Over 10 years, the gap is even starker: CRAI returned +550. 5% versus DLHC's +24. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — DLHC or CRAI?

By beta (market sensitivity over 5 years), CRA International, Inc.

(CRAI) is the lower-risk stock at 0. 73β versus DLH Holdings Corp. 's 0. 82β — meaning DLHC is approximately 13% more volatile than CRAI relative to the S&P 500. On balance sheet safety, CRA International, Inc. (CRAI) carries a lower debt/equity ratio of 60% versus 128% for DLH Holdings Corp. — giving it more financial flexibility in a downturn.

05

Which is growing faster — DLHC or CRAI?

By revenue growth (latest reported year), CRA International, Inc.

(CRAI) is pulling ahead at 9. 3% versus -13. 0% for DLH Holdings Corp. (DLHC). On earnings-per-share growth, the picture is similar: CRA International, Inc. grew EPS 20. 8% year-over-year, compared to -81. 5% for DLH Holdings Corp.. Over a 3-year CAGR, CRAI leads at 8. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — DLHC or CRAI?

CRA International, Inc.

(CRAI) is the more profitable company, earning 7. 3% net margin versus 0. 4% for DLH Holdings Corp. — meaning it keeps 7. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CRAI leads at 11. 1% versus 4. 9% for DLHC. At the gross margin level — before operating expenses — CRAI leads at 29. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Which pays a better dividend — DLHC or CRAI?

In this comparison, CRAI (1.

5% yield) pays a dividend. DLHC does not pay a meaningful dividend and should not be held primarily for income.

08

Is DLHC or CRAI better for a retirement portfolio?

For long-horizon retirement investors, CRA International, Inc.

(CRAI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 73), 1. 5% yield, +550. 5% 10Y return). Both have compounded well over 10 years (CRAI: +550. 5%, DLHC: +24. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

09

What are the main differences between DLHC and CRAI?

Both stocks operate in the null sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: DLHC is a small-cap quality compounder stock; CRAI is a small-cap deep-value stock. CRAI pays a dividend while DLHC does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

DLHC

Quality Business

  • Market Cap > $100B
Run This Screen
Stocks Like

CRAI

Stable Dividend Mega-Cap

  • Sector: Industrials
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 5%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform DLHC and CRAI on the metrics below

Revenue Growth>
%
(DLHC: -33.6% · CRAI: 10.5%)
P/E Ratio<
x
(DLHC: 60.8x · CRAI: 17.1x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.